These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6974307)

  • 1. Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.
    Ben-Nun A; Wekerle H; Cohen IR
    Nature; 1981 Jul; 292(5818):60-1. PubMed ID: 6974307
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuated T-lymphocyte lines as vaccinating agents against experimental autoimmune encephalomyelitis.
    Offner H; Jones R; Vandenbark AA
    Ann N Y Acad Sci; 1988; 540():540-2. PubMed ID: 2462830
    [No Abstract]   [Full Text] [Related]  

  • 3. T cell vaccination in monoclonal antibody-induced hyperacute experimental allergic encephalomyelitis.
    Schluesener HJ; Meyermann R
    J Neuroimmunol; 1989 Oct; 24(3):233-8. PubMed ID: 2478583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific.
    Holoshitz J; Frenkel A; Ben-Nun A; Cohen IR
    J Immunol; 1983 Dec; 131(6):2810-3. PubMed ID: 6196400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination against experimental autoimmune disease using autoimmune T-lymphocytes.
    Cohen IR
    Isr J Med Sci; 1988 Dec; 24(12):734-6. PubMed ID: 2465284
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination against experimental autoimmune diseases using T lymphocytes treated with hydrostatic pressure.
    Lider O; Shinitzky M; Cohen IR
    Ann N Y Acad Sci; 1986; 475():267-73. PubMed ID: 2431645
    [No Abstract]   [Full Text] [Related]  

  • 7. Synapsin-induced proliferation of T-cell lines against myelin basic protein obtained from rats with experimental autoimmune encephalomyelitis.
    Degano AL; Roth GA
    Autoimmunity; 2009; 42(8):661-6. PubMed ID: 19886738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.
    Lobell A; Weissert R; Eltayeb S; de Graaf KL; Wefer J; Storch MK; Lassmann H; Wigzell H; Olsson T
    J Immunol; 2003 Feb; 170(4):1806-13. PubMed ID: 12574345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of permanent T lymphocyte lines with receptors for myelin basic protein (MBP).
    Schluesener HJ; Wekerle H
    Prog Clin Biol Res; 1984; 146():285-90. PubMed ID: 6201900
    [No Abstract]   [Full Text] [Related]  

  • 10. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
    Bouwer HG; Hinrichs DJ
    J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological basis of T-cell vaccination against autoimmune disease.
    Cohen IR
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():879-84. PubMed ID: 2484252
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
    Lohse AW; Mor F; Karin N; Cohen IR
    Science; 1989 May; 244(4906):820-2. PubMed ID: 2471264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with a synthetic T-cell receptor V-region peptide: immunomodulation or vaccination.
    Kaneko H; Iizuka K; Kokai Y; Fujimoto JI; Hirasawa A; Tsujimoto G; Koike H; Torres-Nagel N; Hunig T; Kimura H
    Transplant Proc; 1995 Apr; 27(2):1539-42. PubMed ID: 7536968
    [No Abstract]   [Full Text] [Related]  

  • 14. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
    Vandenbark AA; Gill T; Offner H
    J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cells in experimental allergic encephalomyelitis. I. Frequency and specificity analysis in normal and immune rats of a T cell subset that inhibits disease.
    Sun D; Whitaker JN; Wilson DB
    Int Immunol; 1999 Mar; 11(3):307-15. PubMed ID: 10221642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
    Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
    Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis.
    Burrows GG; Bebo BF; Adlard KL; Vandenbark AA; Offner H
    J Immunol; 1998 Dec; 161(11):5987-96. PubMed ID: 9834080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pillars Article: The Rapid Isolation of Clonable Antigen-specific T Lymphocyte Lines Capable of Mediating Autoimmune Encephalomyelitis.
    Ben-Nun A; Wekerle H; Cohen IR
    J Immunol; 2017 May; 198(9):3384-3388. PubMed ID: 28416716
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective DNA vaccination against experimental autoimmune encephalomyelitis is associated with induction of IFNbeta.
    Wefer J; Harris RA; Lobell A
    J Neuroimmunol; 2004 Apr; 149(1-2):66-76. PubMed ID: 15020066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte vaccination against experimental autoimmune encephalomyelitis: evaluation of vaccination protocols.
    Offner H; Jones R; Celnik B; Vandenbark AA
    J Neuroimmunol; 1989 Jan; 21(1):13-22. PubMed ID: 2521179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.